Crossmark

Long-term response of metastatic hereditary leiomyomatosis and renal cell carcinoma syndrome associated renal cell carcinoma to bevacizumab plus erlotinib after temsirolimus and axitinib treatment failures

Crossref DOI link: https://doi.org/10.1186/s12894-019-0484-2

Published Online: 2019-06-10

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Park, Inkeun https://orcid.org/0000-0003-3064-7895
Shim, Young Sup

Go, Heounjeong

Hong, Bum Sik

Lee, Jae Lyun
License Information

Text and Data Mining valid from 2019-06-10

Version of Record valid from 2019-06-10
More Information

Article History

Received: 28 February 2018

Accepted: 31 May 2019

First Online: 10 June 2019

Ethics approval and consent to participate

: Not applicable.

: Written informed consent was obtained from the patient for the publication of this case report and any accompanying images. The data do not contain any information that could identify the patient.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below